dc.contributor.author |
Laske, Christoph |
|
dc.date.accessioned |
2015-05-19T13:41:23Z |
|
dc.date.available |
2015-05-19T13:41:23Z |
|
dc.date.issued |
2012-10 |
|
dc.identifier.issn |
1759-4758 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/63366 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
New York, NY : Nature Publ. Group |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1038/nrneurol.2012.173 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Alzheimer disease : Blood-based biomarkers in AD--a silver lining on the horizon |
de_DE |
dc.type |
Article |
de_DE |
utue.publikation.seiten |
541-542 |
de_DE |
utue.personen.roh |
Laske, Christoph |
|
dcterms.isPartOf.ZSTitelID |
Nature reviews : Neurology |
de_DE |
dcterms.isPartOf.ZS-Issue |
10 |
de_DE |
dcterms.isPartOf.ZS-Volume |
8 |
de_DE |